Upgrade to SI Premium - Free Trial

Mirati Therapeutics (MRTX) seen worth more than double in a buyout

November 23, 2022 12:40 PM
After surging nearly 16% Tuesday on fresh takeover rumors, Mirati Therapeutics (NASDAQ: MRTX) is adding another 5% Wednesday as Wall ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Hot List Mergers and Acquisitions Rumors

Next Articles